Web Access Research Portal

Researcher: Tegg, EM (Dr Elizabeth Tegg)

Fields of Research

Haematology
Cancer Genetics
Oncology and Carcinogenesis
Cancer Diagnosis
Cardiology (incl. Cardiovascular Diseases)
Medical Genetics (excl. Cancer Genetics)
Clinical Chemistry (diagnostics)
Health and Community Services
Clinical Sciences
Mental Health Nursing
Biochemistry and Cell Biology
Haematological Tumours
Cancer Cell Biology
Tumour Immunology
Cellular Immunology
Molecular Targets
Preventive Medicine

Research Objectives

Cancer and Related Disorders
Blood Disorders
Health
Inherited Diseases (incl. Gene Therapy)
Men's Health
Expanding Knowledge in the Biological Sciences

Career Best Publications

Research Publications

A retrospective examination of mean relative telomere length in the Tasmanian Familial Hematological Malignancies Study; Oncology Reports
Accuracy, reproducibility and clinical utility of the CoaguChek S portable international normalized ratio monitor in an outpatient anticoagulation clinic; Clinical and Laboratory Haematology
Anticipation in familial hematologic malignancies; Blood
Association between high interleukin-6 levels and adverse outcome after autologous haemopoietic stem cell transplantation; Bone Marrow Transplantation
Bone marrow transplantation for patients with advanced breast cancer after >2 chemotherapy regimens; 26th Annual Scientific Meeting of the Clinical Oncological Society of Australia (COSA)
Cytogenetic investigations of chronic lymphocytic leukemia; Cancer Genetics and Cytogenetics
Evidence for a common genetic aetiology in high-risk families with multiple haematological malignancy subtypes ; British Journal of Haematology
Familial Haematological Malignancies; GeneMappers
Familial Haematological malignancies: The Tasmanian experience; Haematology Society of Australia and New Zealand, Australia and New Zealand Society for Blood Transfusion & Australasian Society for Thrombosis and Homeostasis
Hemopoietic stem-cell harvesting and transplantation using G-CSF-primed BM: comparison with unprimed BM and G-CSF-primed PBSC; Cytotherapy
HIT- Are we doing it right ? An audit of Heparin-induced thrombocytopenia testing at Royal Hobart Hospital; Annaul Scientific meeting HAA 2014
Identification of Susceptibility Genes for Haematological Maligancies; GeneMappers
Interleukin-6: a prognostic factor in stem cell transplantation?; The 1st Annual Scientific Meeting of the Haematology Society of Australia & New Zealand
Linkage analysis of a large Tasmanian haematological cancer family; GeneMappers
Retrospective analysis of outcome following autologous haematopoietic stem cell transplantation (HSCT) after long-term (>12) versus short-term (<12 months) cryopreservation; Bone Marrow Transplant Scientists' Association of Australasia
Retrospective analysis of outcome following autologous haematopoietic stem cell transplantation (HSCT) after long-term (>12) versus short-term (<12) months cryopreservation; The 1st Annual Scientific Meeting of the Haematology Society of Australia & New Zealand
Retrospective study of absence of expression of HLA-DR in acute myeloid leukaemia; Pathology Update 2013
The effect of G-CSF on the composition of human bone marrow; 37th National Scientific Conference
The effect of G-CSF on the composition of human bone marrow; Clinical Laboratory Haematology
The Familial Tasmanian Haematological Malignancies Study (FaTHMS): its origins, its history and the phenomenon of anticipation; Transfusion and Apheresis Science
The Tasmanian familial leukaemia and lymphoma research study; Haematology Society of Australia and New Zealand, Australia and New Zealand Society for Blood Transfusion & Australasian Society for Thrombosis and Homeostasis
The Tasmanian familial leukaemia and lymphoma research study; GeneMappers
Transient anti-LW : laboratory nightmare; Annaul Scientific meeting HAA 2014
Use of 'rainy day' autologous haemopoietic stem cells: a single-institution experience over 10 years; Internal Medicine Journal
Whole genome sequencing of CLL case; GeneMappers

Research Projects

Identification of susceptibility genes for familial haematological malignancies; Leukaemia Foundation (LF)
Identifying inherited factors underlying familial haematological malignancies; David Collins Leukaemia Foundation (DCLF)
Investigating the genetics of familial haematological cancers in Tasmania; David Collins Leukaemia Foundation (DCLF)
Regulation of the LIFR Receptor by RUNX1; David Collins Leukaemia Foundation (DCLF)
Tasmania familial haematological malignancy research study; David Collins Leukaemia Foundation (DCLF)
Tasmanian familial haematological malignancy research study; Pfizer (PFIZER)
The Tasmanian Familial Haematological Malignancies Study; Roche Products Pty Ltd (ROCHE)
The Tasmanian Familial Haematological Malignancies Study; Royal Hobart Hospital Research Foundation (RHHRF)
Validation of newly identified genes in the pathogenesis of chronic lymphocytic leukaemia; David Collins Leukaemia Foundation (DCLF)

Research Candidate Supervision